GO
Loading...

Enter multiple symbols separated by commas

Food and Staples Retailing Drug Retail

More

  • InterMune CEO: Drug trials bring hope Tuesday, 25 Feb 2014 | 2:21 PM ET
    InterMune CEO: Drug trials bring hope

    InterMune president & CEO Dan Welch says positive drug trial results bring hope to patients with idiopathic pulmonary fibrosis, and discusses the volatility in its stock.

  • Drugmakers focus on hepatitis C Tuesday, 25 Feb 2014 | 1:40 PM ET
    Drug makers focus on Hepatitis C

    CNBC's Morgan Brennan reports the pharmaceutical companies are developing oral therapies for the condition that could replace current treatments.

  • Target staff say they warned of security flaws Friday, 14 Feb 2014 | 5:48 PM ET

    At least one analyst at Target pushed for an investigation into payment systems after government and industry reports.

  • New pot banking rules Friday, 14 Feb 2014 | 2:01 PM ET
    New marijuana banking rules

    NBC's Pete Williams reports the government has issued guidance for banks servicing legal marijuana businesses. CNBC's Jane Wells provides insight.

  • Roche 2013 sales fall but CEO confident Thursday, 30 Jan 2014 | 12:00 AM ET

    Global healthcare company Roche is confident of growth in emerging markets despite the economic slowdown.

  • Minimum wage windfall? States test the idea Tuesday, 14 Jan 2014 | 3:50 PM ET
    A worker puts together an order of Chicken McNuggets at a McDonald's restaurant in Little Falls, N.J.

    Companies and industries that rely on low-income spenders could see a boost to the bottom line thanks to rising wages in many American states.

  • Exelixis CEO: 30,000 men will die of prostate cancer this year

    Michael Morrissey, Exelixis president & CEO, provides insight on clinical research of prostate cancer and its cancer drug Cometriq.

  • Biogen CEO: More products, company is focused Monday, 13 Jan 2014 | 2:15 PM ET
    Biogen CEO: More products, company is focused

    Biogen Idec CEO George Scangos discusses the busy year ahead for the company, including the EU launch of Tecfidera and when a dividend will be offered.

  • Eli Lilly CEO: Hope to publish migraine data late 2014

    Eli Lilly Chairman & CEO John Lechleiter provides insight on its rights to an experimental migraine drug.

  • Eli Lilly CEO: Strongest late-phase pipeline in our history

    Eli Lilly Chairman & CEO John Lechleiter discusses its loss of major patents, its current pipeline and when its total costs will normalize.

  • The next big drug Monday, 13 Jan 2014 | 1:25 PM ET
    The next big drug

    CNBC's Morgan Brennan reports on the FDA's four expediting pipelines. The approval rates for the drugs in these pipelines tend to be higher than those plodding the more traditional course.

  • Children's top flu medicine in short supply in U.S. Thursday, 9 Jan 2014 | 5:56 PM ET

    But the delay in packaging the liquid version has not affected supplies of regular Tamiflu, said the Roche unit that makes the medication.

  • Neurocrine Biosciences CEO on TD treatment Tuesday, 7 Jan 2014 | 2:35 PM ET
    Neurocrine Biosciences CEO on stock spike

    Neurocrine Biosciences' president and CEO Kevin Gorman, Ph. D., provides insight on clinical trials for its tardive dyskinesia treatment.

  • High Times announces new fund Tuesday, 7 Jan 2014 | 2:27 PM ET
    High Times announces new fund

    CNBC's Josh Lipton reports on the HT Growth Fund, which plans to raise $100 million over the next two years for the legal marijuana market.

  • Tough business of marijuana Tuesday, 7 Jan 2014 | 12:51 PM ET
    Tough business of marijuana

    CNBC's Josh Lipton reports that legal recreational pot businesses could get investment from a fund.

  • Colorado pot: Lighting the licensing way Thursday, 26 Dec 2013 | 11:50 AM ET
    Colorado pot: Lighting the licensing way

    Colorado has issued more than 300 licenses to marijuana dispensaries. Dan Danko, High Times Magazine senior editor, discusses how Colorado is properly regulating pot distribution and explains the rigorous application process to obtain a license.

  • Under ACA, payments to doctors made public Tuesday, 17 Dec 2013 | 1:17 PM ET
    Under ACA, payments to doctors made public

    CNBC's Sara Eisen reports GlaxoSmithKline is becoming the first to stop paying doctors to promote drugs.

  • Cramer: ‘I’m throwing up my hands with this group’ Wednesday, 4 Dec 2013 | 11:16 AM ET

    Muddled by inconsistent earnings and stock performances, one sector appears tougher and tougher to predict, CNBC's Jim Cramer says.

  • Rocky Mountain High-er Friday, 22 Nov 2013 | 10:27 AM ET
    Denver store first to sell recreational pot legally

    A medical marijuana dispensary in Central City, Colo.—a small gambling town nestled in the mountains near Denver—just became the first business in the United States licensed to sell marijuana to patrons without a note from their doctors.

  • Third party sales pit Amazon vs. JNJ: Report Monday, 11 Nov 2013 | 8:37 AM ET

    Amazon.com is clashing with Johnson & Johnson amid complaints the online retailer hasn't stopped sales of damaged or expired products.